MEN1 and primitive neuroectodermal tumor: To evaluate whether metformin is associated with altered PNET outcomes in MEN1, we performed a retrospective analysis of MEN1 patients with PNETs, incorporating detailed clinical exposure data and complemented this analysis with a preclinical study using pancreatic islet β-cell-specific Men1-knockout mice treated with metformin.